Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With Borderline Resectable and Locally Advanced Pancreatic Cancer
Latest Information Update: 08 Apr 2024
At a glance
- Drugs Camrelizumab (Primary) ; Capecitabine; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions
Most Recent Events
- 08 Apr 2024 New trial record